Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

1.23
Delayed Data
As of Aug 18
 -0.06 / -4.65%
Today’s Change
0.70
Today|||52-Week Range
19.80
-72.05%
Year-to-Date

Today’s Trading

Previous close1.29
Today’s open1.27
Day’s range1.17 - 1.28
Volume3,333,526
Average volume (3 months)2,820,839
Market cap$27.3M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+75.05%
Earnings growth (this year)+13.61%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+38.73%
P/E ratioNM
Price/Sales0.61
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
BMRABiomerica Inc+0.08+3.00%
APHBAmpliPhi Biosciences...+0.00+0.52%
TRILTrillium Therapeutic...+0.05+1.12%
GALTGalectin Therapeutic...+0.02+1.12%
Data as of 6:29pm ET, 08/18/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$13.1M
Annual profit (last year)-$9.7M
Net profit margin-64.27%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Jack E. Stover
Senior Vice President-
Operations
Glenn Gershon
Corporate headquarters
Parsippany, New Jersey

Forecasts